100 related articles for article (PubMed ID: 28560803)
1. Troubleshooting the collect concentration monitor alarm in therapeutic thrombocytapheresis.
Linn N; Bryan R; Ross M; Pereyra L; Lin D
J Clin Apher; 2018 Feb; 33(1):95-96. PubMed ID: 28560803
[No Abstract] [Full Text] [Related]
2. [Therapeutic thrombocytapheresis in patients with myeloproliferative diseases with the cell separators Fresenius AS 104 and Cobe Spectra: biocompatibility and safety].
Ullrich H; Kadar J; Waxenberger Y; Hohe R; Saueressig C; Heyder M; Wiebecke D
Beitr Infusionsther; 1992; 30():311-4. PubMed ID: 1284723
[TBL] [Abstract][Full Text] [Related]
3. Managing uncontrolled postsplenectomy reactive thrombocytosis in idiopathic thrombocytopenic purpura: role of thrombocytapheresis.
Das SS; Bhattacharya S; Sen S
Transfus Apher Sci; 2013 Oct; 49(2):171-3. PubMed ID: 23871583
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic thrombocytapheresis for extreme thrombocytosis after chemotherapy in essential thrombocytosis.
Almeida-Dias R; Garrote M; Cid J; Mustieles MJ; Alba C; Lozano M
J Clin Apher; 2019 Aug; 34(4):503-506. PubMed ID: 30624802
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic thrombocytapheresis: a review of 132 patients.
Adami R
Int J Artif Organs; 1993 Dec; 16 Suppl 5():183-4. PubMed ID: 8013984
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Thrombocytapheresis for Symptomatic Thrombocytosis in Hemato-Oncology Patients.
Prakash S; Hans R; Sharma RR; Malhotra P; Marwaha N
Ther Apher Dial; 2018 Feb; 22(1):93-95. PubMed ID: 29205870
[No Abstract] [Full Text] [Related]
7. The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.
Boddu P; Falchi L; Hosing C; Newberry K; Bose P; Verstovsek S
Leuk Res; 2017 Jul; 58():14-22. PubMed ID: 28380402
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic cytapheresis using the Fenwal CS-3000 blood cell separator.
Steeper TA; Smith JA; McCullough J
Vox Sang; 1985; 48(4):193-200. PubMed ID: 3984305
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic thrombocytapheresis in a case of thrombocytosis.
Belloni M; Fabris F; Ongaro G; Girolami A
Transfusion; 1981; 21(2):229-30. PubMed ID: 7222208
[No Abstract] [Full Text] [Related]
11. Rapid reduction of platelet numbers in thrombocytosis.
Liumbruno G; Centoni PE; Ceretelli S; Sodini ML
Ther Apher; 2000 Oct; 4(5):374-6. PubMed ID: 11111819
[TBL] [Abstract][Full Text] [Related]
12. [Thrombocytapheresis with the (Baxter) A 201 cell separator--initial data of biocompatibility].
Moog R; Luboldt W; Krützfeldt A; Paar D; Holtmann M; Mengelkamp AK
Infusionstherapie; 1991 Oct; 18(5):244-7. PubMed ID: 1769738
[TBL] [Abstract][Full Text] [Related]
13. Platelet apheresis for extreme thrombocytosis in an 11-year-old girl with CML.
McCarthy LJ; Graves VL; Eigen H; McGuire WA
Transfus Med; 1991 Sep; 1(3):187-9. PubMed ID: 9259847
[TBL] [Abstract][Full Text] [Related]
14. Safety and feasibility of therapeutic platelet depletion with Spectra Optia in a pregnant woman.
Małachowski R; Grzybowska-Izydorczyk O; Besson N; Szmigielska-Kapłon A; Nowicki M; Wierzbowska A
Transfus Apher Sci; 2017 Aug; 56(4):563-565. PubMed ID: 28803005
[TBL] [Abstract][Full Text] [Related]
15. Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report.
Debureaux PE; Brignier A; Soret-Dulphy J; Réa D; Michonneau D; Peffault de Latour R; Sicre de Fontbrune F; Pagliuca S; Parquet N; Prata HP; Marouf A; Xhaard A; Kiladjian JJ; Socié G; Robin M
Ann Hematol; 2020 Apr; 99(4):897-898. PubMed ID: 32030449
[No Abstract] [Full Text] [Related]
16. Control of thrombocytosis by plateletpheresis using a cell separator.
Beard ME; Blacklock HA; Varcoe AR
N Z Med J; 1980 Feb; 91(654):136-8. PubMed ID: 6929973
[TBL] [Abstract][Full Text] [Related]
17. [Preparation of leukocyte depleted thrombocytapheresis preparations using closed disposable systems with an in-line filter for the AS 104 cell separator].
Moog R; Kalb R; Müller N; Köbke AC
Beitr Infusionsther Transfusionsmed; 1997; 34():114-7. PubMed ID: 9417334
[TBL] [Abstract][Full Text] [Related]
18. [Particle formation in thrombocytapheresis with the cell separator V 50.1].
Misterek J; Strübel G; Neppert J; Rust H; Mueller-Eckhardt C
Beitr Infusionsther; 1988; 21():118-21. PubMed ID: 2462956
[No Abstract] [Full Text] [Related]
19. Therapeutic thrombocytapheresis in myeloproliferative neoplasms: A single-institution experience.
Nguyen TH; Bach KQ; Vu HQ; Nguyen NQ; Duong TD; Wheeler J
J Clin Apher; 2021 Feb; 36(1):101-108. PubMed ID: 33037852
[TBL] [Abstract][Full Text] [Related]
20. Long-term plateletpheresis in the management of primary thrombocytosis.
Goldfinger D; Thompson R; Lowe C; Kurz L; Belkin G
Transfusion; 1979; 19(3):336-8. PubMed ID: 452073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
